COMMONWEALTH OF AUSTRALIA
Department of Health
Therapeutic Goods Administration
THERAPEUTIC GOODS ACT 1989
Section 14 and 14A Notice
On 12 June 2015, the delegate of the Secretary of the Department of Health for the purposes of subsection 14 and 14A of the Therapeutic Goods Act 1989 (“the Act”), on the application of AFT Pharmaceuticals, gave consent to the importation and supply of
- Lax-Tab bisacodyl 5mg tablet bottle AUST R 119101; and
- Lax-Tab bisacodyl 5mg tablet blister pack AUST R 119125
that do not conform with the requirements of the section 8 of the Therapeutic Goods Order No. 78 Standard for Tablets and Capsules, in that the products do not comply with the dissolution requirement of the British Pharmacopoeia monograph for Gastro-resistant Bisacodyl Tablets..
The consent is effective until 30 June 2017.